The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

GNF-PF-1199     2-phenylethanamide

Synonyms: PubChem13418, CPD-238, SureCN25676, AGN-PC-0D9X2J, CHEMBL347645, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Phenylacetic acid amide


High impact information on Phenylacetic acid amide


Biological context of Phenylacetic acid amide

  • Selective and enantiospecific acylation of kappa opioid receptors by (1S,2S)-trans-2-isothiocyanato-N-methyl-N-[2-(1-pyrrolidinyl) cyclohexy l] benzeneacetamide. Demonstration of kappa receptor heterogeneity [9].
  • BW942C was less efficacious in producing diuresis than the full kappa agonists bremazocine and U50,488H (trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl]- benzeneacetamide methanesulfonate, hydrate) [10].
  • A kappa (kappa) opioid binding site has been characterized on the macrophage cell line, P388d1, using the kappa selective affinity ligand, [3H] (1S,2S)-(-)-trans-2-isothiocyanato-N-methyl-N-[2-(1- pyrrolidinyl) cyclohexyl] benzeneacetamide (-)BD166) [11].

Anatomical context of Phenylacetic acid amide


Associations of Phenylacetic acid amide with other chemical compounds

  • In the mouse abdominal constriction test, pretreatment with the nitric oxide synthase (NOS) inhibitor L-NG-nitroarginine (L-NOARG) caused dose-related antagonism of the antinociceptive effect of N2O but not of either morphine or trans(+/-)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl] benzeneacetamide methane sulfonate [14].
  • VTA microinjections of (trans-(dl)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclo-hexyl]- benzeneacetamide) methane sulfonate hydrate (U-50,488H); a kappa agonist) failed to alter ventral striatal DA concentrations at any dose tested, but subsequent systemic injections significantly decreased DA and DA-metabolite concentrations [15].
  • U-50,488, (trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl]- benzeneacetamide hydrochloride), is a selective kappa-opioid receptor agonist [16].
  • A mutation in a gene designated gmdA has been found to lead to loss of ability of Aspergillus nidulans to use benzamide, phenylacetamide and several other amides as sole nitrogen sources for growth [17].

Gene context of Phenylacetic acid amide


  1. Beneficial effects of the kappa opioid receptor agonist U-50488H in experimental acute brain and spinal cord injury. Hall, E.D., Wolf, D.L., Althaus, J.S., Von Voigtlander, P.F. Brain Res. (1987) [Pubmed]
  2. Adaptation to phenylacetamide as a growth substrate by an acetanilide-utilizing mutant of Pseudomonas aeruginosa. Gregoriou, M., Brown, P.R. Arch. Microbiol. (1980) [Pubmed]
  3. Atenolol developmental toxicity: animal-to-human comparisons. Tabacova, S., Kimmel, C.A., Wall, K., Hansen, D. Birth defects research. Part A, Clinical and molecular teratology. (2003) [Pubmed]
  4. Mu opioid transactivation and down-regulation of the epidermal growth factor receptor in astrocytes: implications for mitogen-activated protein kinase signaling. Belcheva, M.M., Tan, Y., Heaton, V.M., Clark, A.L., Coscia, C.J. Mol. Pharmacol. (2003) [Pubmed]
  5. Ligand-induced conformational change in penicillin acylase. Done, S.H., Brannigan, J.A., Moody, P.C., Hubbard, R.E. J. Mol. Biol. (1998) [Pubmed]
  6. Regional, developmental, and cell cycle-dependent differences in mu, delta, and kappa-opioid receptor expression among cultured mouse astrocytes. Stiene-Martin, A., Zhou, R., Hauser, K.F. Glia (1998) [Pubmed]
  7. Synthesis and quantitative structure-activity relationships of N-(1-benzylpiperidin-4-yl)phenylacetamides and related analogues as potent and selective sigma1 receptor ligands. Huang, Y., Hammond, P.S., Whirrett, B.R., Kuhner, R.J., Wu, L., Childers, S.R., Mach, R.H. J. Med. Chem. (1998) [Pubmed]
  8. Differential agonist regulation of the human kappa-opioid receptor. Blake, A.D., Bot, G., Li, S., Freeman, J.C., Reisine, T. J. Neurochem. (1997) [Pubmed]
  9. Selective and enantiospecific acylation of kappa opioid receptors by (1S,2S)-trans-2-isothiocyanato-N-methyl-N-[2-(1-pyrrolidinyl) cyclohexy l] benzeneacetamide. Demonstration of kappa receptor heterogeneity. de Costa, B.R., Rothman, R.B., Bykov, V., Jacobson, A.E., Rice, K.C. J. Med. Chem. (1989) [Pubmed]
  10. Kappa opioid partial agonist activity of the enkephalin-like pentapeptide BW942C based on urination and in vitro studies in humans and animals. Vaupel, D.B., Cone, E.J., Johnson, R.E., Su, T.P. J. Pharmacol. Exp. Ther. (1990) [Pubmed]
  11. Enantioselective kappa opioid binding sites on the macrophage cell line, P388d1. Carr, D.J., DeCosta, B.R., Jacobson, A.E., Rice, K.C., Blalock, J.E. Life Sci. (1991) [Pubmed]
  12. Opioid receptors mediate a postsynaptic facilitation and a presynaptic inhibition at the afferent synapse of axolotl vestibular hair cells. Vega, R., Soto, E. Neuroscience (2003) [Pubmed]
  13. Inhibition of L-type calcium currents in guinea pig ventricular myocytes by the kappa-opioid agonist U50488H does not involve binding to opiate receptors. Utz, J., Eckert, R., Trautwein, W. J. Pharmacol. Exp. Ther. (1995) [Pubmed]
  14. Inhibitors of nitric oxide synthesis antagonize nitrous oxide antinociception in mice and rats. McDonald, C.E., Gagnon, M.J., Ellenberger, E.A., Hodges, B.L., Ream, J.K., Tousman, S.A., Quock, R.M. J. Pharmacol. Exp. Ther. (1994) [Pubmed]
  15. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. Devine, D.P., Leone, P., Pocock, D., Wise, R.A. J. Pharmacol. Exp. Ther. (1993) [Pubmed]
  16. U-50,488 blocks the development of morphine tolerance and dependence at a very low dose in guinea pigs. Tao, P.L., Hwang, C.L., Chen, C.Y. Eur. J. Pharmacol. (1994) [Pubmed]
  17. Amide utilization in Aspergillus nidulans: evidence for a third amidase enzyme. Hynes, M.J. J. Gen. Microbiol. (1975) [Pubmed]
  18. The kappa-opioid receptor agonist, U50,488H, exerts antidystonic activity in a mutant hamster model of generalized dystonia. Richter, A., Löscher, W. Eur. J. Pharmacol. (1993) [Pubmed]
  19. Substitutions of Thr-103-Ile and Trp-138-Gly in amidase from Pseudomonas aeruginosa are responsible for altered kinetic properties and enzyme instability. Karmali, A., Pacheco, R., Tata, R., Brown, P. Mol. Biotechnol. (2001) [Pubmed]
WikiGenes - Universities